PRESS RELEASE published on 07/15/2025 at 10:00, 7 months 5 days ago Mallia Innovations appoints five leading international experts in hair science to its Scientific Advisory Board Mallia Innovations appoints five leading international experts in hair science to its Scientific Advisory Board. The experts bring expertise in hair biology, dermatology, clinical development, and biotech innovation Scientific Advisory Board Mallia Innovations Biopharmaceutical Therapies Hair Science SCD83-based Candidates
BRIEF published on 07/01/2025 at 10:05, 7 months 19 days ago Mallia Innovations Enhances Advisory Board with Key Appointments Advisory Board Biopharmaceutical Mallia Innovations Hair Growth SCD83 Therapies
BRIEF published on 07/01/2025 at 10:05, 7 months 19 days ago Mallia Innovations renforce son conseil consultatif avec des nominations clés Biopharmaceutique Conseil Consultatif Mallia Innovations Croissance Des Cheveux Thérapies SCD83
PRESS RELEASE published on 07/01/2025 at 10:00, 7 months 19 days ago Mallia Innovations: Mallia Appoints Jens Holstein, Dr. Alexandra Ogilvie, and Dr. Ulrich Dauer to its Advisory Board Mallia Innovations appoints Jens Holstein, Dr. Alexandra Ogilvie, and Dr. Ulrich Dauer to its Advisory Board, strengthening expertise in biopharmaceutical and dermatology sectors Advisory Board Biopharmaceutical Dermatology Mallia Innovations SCD83-based Therapies
BRIEF published on 06/24/2025 at 10:05, 7 months 26 days ago Mallia vise à révolutionner la croissance des cheveux avec sCD83 au HairS'25 Innovation Cosmétique SCD83 Croissance Des Cheveux Alopécie Symposium HairS'25
BRIEF published on 06/24/2025 at 10:05, 7 months 26 days ago Mallia Aims to Revolutionize Hair Growth with sCD83 at HairS'25 Cosmetic Innovation SCD83 Alopecia Hair Growth HairS’25 Symposium
PRESS RELEASE published on 06/24/2025 at 10:00, 7 months 26 days ago Mallia Aesthetics: Mallia to Showcase Innovative sCD83-Based Approach for Hair Growth at HairS‘25 Symposium Mallia Aesthetics to present innovative sCD83-based approach for hair growth at HairS'25 Symposium, showcasing scientific research and cosmetic innovation Cosmetic Innovation Hair Growth Mallia Aesthetics SCD83-based Approach HairS'25 Symposium
BRIEF published on 06/11/2025 at 10:05, 8 months 9 days ago Mallia Innovations obtient un brevet européen pour le sCD83 Brevet Européen Protéine SCD83 Mallia Innovations Croissance Des Cheveux Cicatrisation Des Plaies
BRIEF published on 06/11/2025 at 10:05, 8 months 9 days ago Mallia Innovations Secures European Patent for sCD83 European Patent Wound Healing SCD83 Protein Mallia Innovations Hair Growth
PRESS RELEASE published on 06/11/2025 at 10:00, 8 months 9 days ago Mallia Secures European Patent Covering sCD83 for Hair Growth and Wound Healing Mallia Innovations secures European patent for sCD83 protein, promoting hair growth and wound healing. Patent covers therapeutic and cosmetic applications, enhancing Mallia's novel treatment development European Patent Wound Healing SCD83 Protein Mallia Innovations Hair Growth
Published on 02/20/2026 at 20:15, 1 hour 28 minutes ago Lithium South Announces Results of its Annual and Special Meeting of Securityholders
Published on 02/20/2026 at 20:15, 1 hour 28 minutes ago Verdera Energy Announces Closing of Qualifying Transaction
Published on 02/20/2026 at 18:30, 3 hours 13 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 5 hours 58 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 7 hours 13 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 18:36, 3 hours 6 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 3 hours 12 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 3 hours 43 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 3 hours 43 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 19:29, 2 hours 14 minutes ago SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 2 hours 14 minutes ago SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 3 hours 43 minutes ago TERACT - Résiliation du contrat de liquidité